Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

MPA increases cancer spread by boosting Eph A2 activity.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

UC.145 may be a new biomarker for predicting gastric cancer.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

CD99 is highly present in certain skin cells and could help treat skin conditions.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Targeting CD169+ skin macrophages may help treat psoriasis.

TB and BCC tumors show similar follicular differentiation patterns.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.